FINWIRES · TerminalLIVE
FINWIRES

$CTEV

11 stories mentioning CTEVUpdated 16d ago

Every FINWIRES story that references CTEV, newest first.

Sectors

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.9%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, the US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported. Claritev shares fell 5.1%.HCA Healthcare (HCA) shares dropped 7.2% after the company lowered its 2026 adjusted diluted EPS guidance. Stephens cut its price target on the stock to $480 from $500, while keeping its overweight rating.IM8, a nutritional supplements company co-founded by Prenetics Global (PRE) and David Beckham, has lined up about $1 billion in growth financing from General Catalyst, Bloomberg reported. Prenetics shares jumped 17%.NextCure (NXTC) shares almost tripled after the company agreed to merge with privately held Avere Therapeutics in an all-stock deal.

$CTEV$HCA$NXTC$PRE
Wire

Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev

(Updates with Claritev's response in the fourth paragraph.)The US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported Tuesday, citing people with knowledge of the matter.The lawsuits accuse the healthcare technology firm of conspiring with UnitedHealth Group (UNH), CVS Health's (CVS) Aetna and Cigna Group (CI) and other health insurers to lower reimbursements for out-of-network services, the report said."We decline to comment on any matters before the DOJ, according to longstanding policy," a DOJ spokesperson told. "However, we can affirm that under the Trump Administration this DOJ will continue to prioritize affordability for all Americans across our economy.""Claritev previously disclosed both the closure of the DOJ's criminal antitrust investigation and the company's receipt of a civil investigative demand ("CID")," a Claritev spokesperson said in an emailed statement to. "The CID does not make findings or allegations, and Claritev is fully cooperating with the DOJ in providing the information it seeks."(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $28.59, Change: $-1.26, Percent Change: -4.21%

$CI$CTEV$CVS$UNH
Wire

Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev

(Update with the Justice Department's response to a request for comment in the third paragraph.)The US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported Tuesday, citing people with knowledge of the matter.The lawsuits accuse the healthcare technology firm of conspiring with UnitedHealth Group (UNH), CVS Health's (CVS) Aetna and Cigna Group (CI) and other health insurers to lower reimbursements for out-of-network services, the report said."We decline to comment on any matters before the DOJ, according to longstanding policy," a DOJ spokesperson told. "However, we can affirm that under the Trump Administration this DOJ will continue to prioritize affordability for all Americans across our economy."Claritev didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $26.49, Change: $-3.35, Percent Change: -11.23%

$CI$CTEV$CVS$UNH
Sectors

Sector Update: Healthcare Stocks Fall Tuesday Afternoon

Healthcare stocks were lower Tuesday afternoon, with the NYSE Healthcare Index down 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1.8%.The iShares Biotechnology ETF (IBB) was fractionally lower.In corporate news, the US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported. Claritev shares fell past 11%.HCA Healthcare (HCA) shares dropped 7.3% after the company lowered its 2026 adjusted diluted EPS guidance. Stephens cut the company's price target to $480 from $500, while keeping its overweight rating.NextCure (NXTC) will merge with privately held Avere Therapeutics in an all-stock deal to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said. NextCure shares surged 200%.

$CTEV$HCA$NXTC
Wire

Market Chatter: DOJ Expands Antitrust Probe Into Claritev

The US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported Tuesday, citing people with knowledge of the matter.The lawsuits accuse the healthcare technology firm of conspiring with UnitedHealth Group (UNH), CVS Health's (CVS) Aetna and Cigna Group (CI) and other health insurers to lower reimbursements for out-of-network services, the report said.Claritev and the Justice Department didn't immediately reply to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $27.91, Change: $-1.93, Percent Change: -6.47%

$CI$CTEV$CVS$UNH
Wire

DOJ Expands Antitrust Probe of Claritev, Bloomberg Reports

DOJ Expands Antitrust Probe of Claritev, Bloomberg Reports

$CTEV
Research

Canaccord Genuity Initiates Claritev at Buy With $32 Price Target

Claritev Corporation Class A (CTEV) has an average rating of overweight and mean price target of $41.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$CTEV
Sectors

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks rose late Monday afternoon, with the NYSE Healthcare Index and the State Street Healthcare Select Sector SPDR ETF (XLV) each adding 0.4%.The iShares Biotechnology ETF (IBB) was shedding 1.6%.In corporate news, Boston Scientific (BSX) shares jumped 6% after it said Monday that it invested $1.5 billion for an approximately 34% stake in privately held MiRus, gaining an exclusive option to acquire the company's TAVR business. Separately, Boston Scientific entered into a $2 billion accelerated share repurchase agreement with JPMorgan Chase (JPM) as part of its $5 billion share buyback authorization.Claritev (CTEV) shares jumped past 19% after the company issued a response to a Thursday media article stating that the Department of Justice has launched a criminal probe into Claritev. The company said Monday it has not been informed by the DOJ that it is the target of an investigation at no point in the subsequent two years after receiving a 2024 subpoena.Eli Lilly (LLY) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders. Lilly shares fell 1.7%.Berkshire Hathaway (BRK.A, BRK.B) said Friday in a regulatory filing that it sold all of its stake in UnitedHealth (UNH). UnitedHealth shares were down 0.8%.

$BSX$CTEV$LLY$UNH
Sectors

Sector Update: Healthcare Stocks Advance Monday Afternoon

Healthcare stocks rose Monday afternoon, with the NYSE Healthcare Index adding 0.4% and the State Street Healthcare Select Sector SPDR ETF (XLV) up 0.3%.The iShares Biotechnology ETF (IBB) was shedding 1.5%.In corporate news, Claritev (CTEV) shares jumped 28% after the company issued a response to a Thursday media article stating that the Department of Justice has launched a criminal probe into Claritev. The company said Monday it has not been informed by the DOJ that it is the target of an investigation at no point in the subsequent two years after receiving a 2024 subpoena.Eli Lilly (LLY) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders. Lilly shares fell 1.4%.Berkshire Hathaway (BRK.A, BRK.B) said Friday in a regulatory filing that it sold all of its stake in UnitedHealth (UNH). UnitedHealth shares were down 1.4%.

$CTEV$LLY$UNH
Wire

Sector Update: Healthcare

Healthcare stocks rose Monday afternoon, with the NYSE Healthcare Index and the State Street Healthcare Select Sector SPDR ETF (XLV) each adding 0.4%.The iShares Biotechnology ETF (IBB) was shedding 1.3%.In corporate news, Claritev (CTEV) shares jumped 24% after the company issued a response to a Thursday media article stating that the Department of Justice has launched a criminal probe into Claritev. The company said Monday it has not been informed by the DOJ that it is the target of an investigation at no point in the subsequent two years after receiving a 2024 subpoena.

$CTEV
Wire

Claritev Says Not Informed by DOJ That Company is Under Investigation

Claritev (CTEV) said Monday it has not been informed by the Department of Justice that Claritev is the target of an investigation, in response to a Thursday media article stating that the DOJ has launched a criminal probe into the company.In August 2024, Claritev received a confidential grand jury subpoena issued by DOJ's Antitrust Division regarding an investigation about health insurance and has been cooperating fully with the DOJ, the company said in a filing with the US Securities and Exchange Commission.Shares of the company were up 18% in Monday trading.Price: $17.00, Change: $+3.13, Percent Change: +22.53%

$CTEV

Track with the FINWIRES app suite

FolioX
FolioX
Track CTEV in your portfolio
WheelAI
WheelAI
Analyze CTEV options with the wheel strategy
StockInsider
StockInsider
See market sentiment on CTEV